Jane Street Group, LLC Apellis Pharmaceuticals, Inc. Put Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $7.88 Million - $11.3 Million	273,400 New	273,400 $7.88 Million
Q1 2022 May 17, 2022	BUY	$35.46 - $54.12 $3.77 Million - $5.75 Million	106,300 Added 292.84%	142,600 $7.25 Million
Q4 2021 Feb 15, 2022	SELL	$30.74 - $49.16 $24.5 Million - $39.2 Million	-798,000 Reduced 95.65%	36,300 $1.72 Million
Q3 2021 Nov 16, 2021	BUY	$31.4 - $69.84 $24.2 Million - $53.9 Million	772,000 Added 1239.17%	834,300 $27.5 Million
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $2.07 Million - $3.28 Million	50,600 Added 432.48%	62,300 $3.94 Million
Q4 2020 Feb 17, 2021	SELL	$30.79 - $57.2 $372,559 - $692,120	-12,100 Reduced 50.84%	11,700 $669,000
Q3 2020 Nov 17, 2020	BUY	$25.89 - $33.65 $168,285 - $218,725	6,500 Added 37.57%	23,800 $718,000
Q2 2020 Aug 17, 2020	BUY	$24.8 - $38.49 $429,040 - $665,877	17,300 New	17,300 $565,000

308

115M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.